(Q38535040)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26101226%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

0 references

3 references

26 October 2020

25 November 2020

Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26101226%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

3 references

6 August 2019

26 October 2020

25 November 2020

pharmaceutical preparation

1 reference

6 August 2019

organ transplantation

2 references

25 November 2020

1 reference

immunosuppressive drug

1 reference

26 October 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26101226%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Greg Knoll

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26101226%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Amber O Molnar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26101226%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Dean Fergusson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26101226%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Anne K Tsampalieros

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26101226%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Alexandria Bennett

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26101226%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Nicholas Fergusson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26101226%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

language of work or name

English

0 references

publication date

22 June 2015

4 references

6 August 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26101226%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

26 October 2020

25 November 2020

4 references

6 August 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26101226%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

26 October 2020

25 November 2020

350

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26101226%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

h3163

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26101226%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial 4.0 International

17 February 2020

copyright license

3 references

6 August 2019

26 October 2020

Checklists of methodological issues for review authors to consider when including non-randomized studies in systematic reviews

25 November 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Is it ethical to prescribe generic immunosuppressive drugs to renal transplant patients?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Systematic conversion to generic tacrolimus in stable kidney transplant recipients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Conversion to generic cyclosporine A in stable chronic patients after heart transplantation.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Clinical outcomes after conversion from brand-name tacrolimus (prograf) to a generic formulation in renal transplant recipients: a retrospective cohort study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

A pilot study on the safety and efficacy of generic mycophenolate agent as conversion maintenance therapy in stable liver transplant recipients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

A randomized pharmacokinetic study of generic tacrolimus versus reference tacrolimus in kidney transplant recipients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Comparative pharmacokinetic study of two mycophenolate mofetil formulations in stable kidney transplant recipients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Generic immunosuppression in solid organ transplantation: a Canadian perspective

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Results of a phase 4 trial of Tacrobell® in liver transplantation patients: a multicenter study in South Korea

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

The role of generics in kidney transplant: mycophenolate mofetil 500 versus mycophenolate: 2-year results.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Safe conversion to cicloral, a generic cylosporine, in both stable and de novo renal transplant recipients.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Generic drug immunosuppression in thoracic transplantation: an ISHLT educational advisory.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Does bioequivalence between modified cyclosporine formulations translate into equal outcomes?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Meta-analyses involving cross-over trials: methodological issues

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

United States Food and Drug Administration requirements for approval of generic drug products.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Recommendations for bioequivalence testing of cyclosporine generics revisited

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Drug substitution in transplantation: a National Kidney Foundation White Paper

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

KDIGO clinical practice guideline for the care of kidney transplant recipients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Bioequivalence requirements for generic products

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Pilot study on the efficacy and safety of generic mycophenolate mofetil (Mycept) compared with Cellcept among incident low-risk primary kidney transplant recipients

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Interchangeability of ciclosporin formulations in stable adult renal transplant recipients: comparison of Equoral and Neoral capsules in an international, multicenter, randomized, open-label trial

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

A bioavailability study of cyclosporine: comparison of Neoral versus Cysporin in stable heart transplant recipients

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

One-Year Multicenter Double-Blind Randomized Clinical Trial on the Efficacy and Safety of Generic Cyclosporine (Iminoral) in De Novo Kidney Transplant Recipients

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

A multicenter experience with generic tacrolimus conversion

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Canadian Society of Transplantation and Canadian Society of Nephrology commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Maintenance immunosuppressive therapy and generic cyclosporine A use in adult renal transplantation: a single center analysis.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Do we have the same clinical results with Neoral and Equoral treatment in kidney transplant recipients? A pilot study

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Assessment of the bioequivalence of a generic cyclosporine A by a randomized controlled trial in stable renal recipients

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Switchability of neoral and equoral according to Food and Drug Administration rules and regulations.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

The utility of the population approach applied to bioequivalence in patients: comparison of 2 formulations of cyclosporine

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Switchover to generic cyclosporine in stable renal transplant recipients: a single unit experience

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

The pharmacokinetics of equoral versus neoral in stable renal transplant patients: a multinational multicenter study

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Bioequivalence of a new cyclosporine a formulation to Neoral

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Bioequivalence and other unresolved issues in generic drug substitution

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Report of the American Society of Transplantation Conference on Immunosuppressive Drugs and the Use of Generic Immunosuppressants

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Neoral-to-Gengraf conversion in renal transplant recipients

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Comparison of peak and trough level monitoring of cyclosporine treatment using two modern cyclosporine preparations.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Conversion of stable renal allograft recipients to a bioequivalent cyclosporine formulation

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4476317

Converting to a generic formulation of mycophenolate mofetil in stable kidney transplant recipients: 1 year of drug surveillance and outcome

31 August 2018

1 reference

12 December 2020

A one-year comparative study of Neoral vs Consupren in de novo renal transplant patients

1 reference

12 December 2020

Neoplanta as a new microemulsion formula of cyclosporine in renal transplantation: comparative study with Neoral for efficacy and safety

1 reference

12 December 2020

Clinical outcomes associated with conversion from brand-name to generic tacrolimus in hospitalized kidney transplant recipients

1 reference

12 December 2020

Safety and efficacy of generic cyclosporine arpimune in Filipino low-risk primary kidney transplant recipients

1 reference

12 December 2020

Comparison of generic cyclosporine microemulsion versus neoral in de novo renal transplant recipients managed by 2-hour postdose monitoring

1 reference

12 December 2020

Immunosuppression, generic drugs and the FDA

1 reference

12 December 2020

Cyclosporine pharmacokinetics in stable renal transplant patients: effect of formulation Sandimmun versus Consupren versus Neoral

1 reference

12 December 2020

Immunosuppressive regimens containing generic mycophenolate mofetil (Myfenax) in de novo renal transplant recipients--preliminary results of 6-month observation

1 reference

12 December 2020

Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed

1 reference

12 December 2020

Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients

1 reference

12 December 2020

Comparison of the efficacy and safety of Consupren solution and Sandimmun Neoral solution, 50 ml in stable heart transplant patients

1 reference

12 December 2020

Generic substitution: additional challenge for adherence in hypertensive patients?

1 reference

12 December 2020

Pharmacokinetics, efficacy, and safety of Iminoral compared with Neoral in healthy volunteers and renal transplant recipients

1 reference

12 December 2020

Pharmacokinetic conversion study of a new cyclosporine formulation in stable adult renal transplant recipients

1 reference

12 December 2020

Generic tacrolimus in renal transplantation: trough blood concentration as a surrogate for drug exposure

1 reference

12 December 2020

A survey to determine the views of renal transplant patients on generic substitution in the UK

1 reference

12 December 2020

European Society for Organ Transplantation Advisory Committee recommendations on generic substitution of immunosuppressive drugs

1 reference

12 December 2020

Immunosuppression, generic drugs and the FDA

1 reference

12 December 2020

The clinical impact of 1:1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function

1 reference

12 December 2020

Therapeutic equivalence and mg:mg switch ability of a generic cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients maintained on Sandimmun Neoral

1 reference

12 December 2020

Development of Sang-35: a cyclosporine formulation bioequivalent to Neoral

1 reference

12 December 2020

Therapeutic equivalence and pharmacokinetics of generic tacrolimus formulation in de novo kidney transplant patients

1 reference

12 December 2020

Assessing lay beliefs about generic medicines: Development of the generic medicines scale

1 reference

12 December 2020

The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function

1 reference

12 December 2020

A physician survey on generic drugs and substitution of critical dose medications

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.H3163

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26101226%20AND%20SRC:MED&resulttype=core&format=json

release_gszumhm4ljgsrgqg33nh2rrw2m

17 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gszumhm4ljgsrgqg33nh2rrw2m

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26101226%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26101226%20AND%20SRC:MED&resulttype=core&format=json